https://www.pharmaceutical-technology.com/news/incyte-non-segmental-vitiligo-treatment-approved-in-uk/

https://www.pharmaceutical-technology.com/news/incyte-non-segmental-vitiligo-treatment-approved-in-uk/

https://www.pharmaceutical-technology.com/news/incyte-ec-opzelura-vitiligo/

https://www.pharmaceutical-technology.com/news/incyte-ec-opzelura-vitiligo/

Vitiligo and COVID Vaccines

Take a look at key takeaways from “Dr. Rich” on COVID-19 vaccines and vitiligo.

FDA Voice of the Patient Report

Amit G. Pandya, MD

Amit G. Pandya, MD, FAAD

Dr. Amit G. Pandya began his GVF presidency on September 1, 2021.

Incyte Clinical Trials Results

New Educational Series

We are very excited to announce a new educational series brought to you by the Global Vitiligo Foundation Communications Committee called, “Living Well with Vitiligo”!

GVF Scientific Symposium Canceled

December 2019 – GVF Board Strategic Planning Meeting

Clinical Trial Results